ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025
The first 25 years of the Northwestern University SuperAging Program.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A lifespan staging model of basal forebrain cholinergic vulnerability.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Review
- The puzzling duality of mesenchymal stem cells and adipocytes in bone marrow and ageing.npj aging · 2026Review
- Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks?Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- Transcriptomic and protein analysis of human cortex reveals genes and pathways linked to NPTX2 disruption in Alzheimer's disease.bioRxiv : the preprint server for biology · 2025Article
- The first 25 years of the Northwestern University SuperAging Program.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
During late life, "average" does not mean "intact." For example, cross-sectional data from a common word list learning test show that average delayed word recall raw score at age 80 (5/15) is approximately half that at age 56 to 66 (9/15). Cognitive and neurobiological dissolution is therefore implicitly incorporated into concepts of the aging brain. This position is being challenged through investigations on "superaging," a term that was coined at the Northwestern Alzheimer's Disease Research Center (ADRC) to define persons ≥ 80 years with delayed word recall raw scores at least equal to those of individuals 20 to 30 years younger. During the first 25 years of this program we established that superagers constitute not only a neuropsychological but also a neurobiological phenotype distinctive from cognitively average age peers. With respect to brain structure, superagers have cortical volumes no different than neurotypical adults 20 to 30 years younger in contrast to neurotypical peers who do show such age-related shrinkage; they also have a region in the cingulate gyrus that is thicker than younger neurotypical adults. With respect to cellular biology, superagers have fewer Alzheimer's disease-type changes in the brain, greater size of entorhinal neurons, fewer inflammatory microglia in white matter, better preserved cholinergic innervation, and a greater density of evolutionarily progressive von Economo neurons. In the future, deeper characterization of the superaging phenotype may lead to interventions that enhance resistance and resilience to involutional changes considered part of average (i.e., "normal") brain aging. This line of work is helping to revise common misperceptions about the cognitive potential of senescence and has inspired investigations throughout the United States and abroad. HIGHLIGHTS: "Normal cognitive aging" is a term that spans a broad spectrum from average for age to well beyond. "Superaging" at the Northwestern University Alzheimer's Disease Research Center (ADRC) refers to a unique cognitive and biological phenotype. Post mortem findings support resilience and resistance to neuropathologic changes of aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.